Press Release: Europe Glucagon-like Peptide-1 (GLP-1) Agonists Research Report 2025 | Market to Reach $14.34 Billion by 2034, Driven by Innovative R&D, Strategic Collaborations, and Drug Formulation Advancements
Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The Europe glucagon-like peptide-1 (GLP-1) agonists market is projected to witness significant growth, fueled primarily by an increased prevalence of type 2 diabetes and obesity. Originally valued at USD 7.09 billion…
TOKYO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) today announced the M5241 Memory Handler, its next-generation handler developed to meet the performance, automation and cost-efficiency demands of emerging high-performance memory devices—particularly those used in artificial intelligence (AI) applications. First shipments of the new handler are scheduled for…
CALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. (TSX: CNE) (OTCID: CNNEQ) (BVC: CNEC) (“Canacol” or the “Company”) announces that it has entered into an agreement with an ad hoc group of holders of the Company’s 5.75% senior unsecured notes due 2028 (the “DIP Credit Agreement”) for debtor-in-possession financing (the “DIP Financing”),…
BRISBANE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera Therapeutics”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced the pricing of an underwritten public offering of 6,138,108 shares of its Class A common stock at a price to the public…
VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce that its Board of Directors has authorized the Corporation to proceed with a normal course issuer bid (the “NCIB”) to purchase for cancellation, from time to time, as the Corporation considers…
NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- OpenBet, a leading global provider of betting technology, content, and services, today announced a landmark collaboration with Fanatics Betting & Gaming, to deploy its full Protect Suite, integrating OpenBet Locator™, the company’s advanced geolocation and fraud prevention solution and Neccton, OpenBet’s AI-enhanced responsible gaming and AML platform.
